Zobrazeno 1 - 10
of 14
pro vyhledávání: '"F M, Gordin"'
Autor:
K, Zahnow, J P, Matts, D, Hillman, E, Finley, L S, Brown, R A, Torres, J, Ernst, W, El-Sadr, G, Perez, C, Webster, B, Barber, F M, Gordin
Publikováno v:
Infection control and hospital epidemiology. 19(11)
To assess the prevalence of tuberculosis (TB) or a positive skin test in healthcare workers (HCWs) providing services to human immunodeficiency virus (HIV)-infected individuals and to determine prospectively the incidence of new infections in this po
Autor:
D A, Benator, F M, Gordin
Publikováno v:
Seminars in respiratory infections. 11(4)
Because of their often profound immune suppression, persons with HIV-infection are, increasingly, being identified as having morbidity related to mycobacteria. Indeed, mycobacterial disease is now the second most frequent cause of illness in AIDS pat
Autor:
M S, Simberkoff, P M, Hartigan, J D, Hamilton, P L, Day, G R, Diamond, G M, Dickinson, G L, Drusano, M J, Egorin, W L, George, F M, Gordin, C A, Hawkes, P C, Jensen, N G, Kilmas, A M, Labriola, W A, O'Brien, C N, Oster, K J, Weinhold, N P, Wray, S B, Pazner
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 11(2)
Following a 4-year controlled trial comparing early and later zidovudine treatment, we conducted an additional 3-year follow-up. Of the original 338 patients, 275 participated. Clinical outcome measures were AIDS and death. In the early therapy group
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 19(1)
The incidence of infection with Mycobacterium avium complex (MAC) is increasing among patients with AIDS. Although numerous antimicrobial regimens have been proposed as treatment for this infection, it is unclear which therapy is most effective. For
Publikováno v:
The Journal of infectious diseases. 169(4)
Delayed-type hypersensitivity (DTH) testing was evaluated as a predictor of human immunodeficiency virus (HIV) disease progression in 336 symptomatic patients with baseline CD4 cell counts of 200-500/mm3 who were participating in a randomized trial o
Autor:
J D, Hamilton, P M, Hartigan, M S, Simberkoff, P L, Day, G R, Diamond, G M, Dickinson, G L, Drusano, M J, Egorin, W L, George, F M, Gordin
Publikováno v:
The New England journal of medicine. 326(7)
Zidovudine is recommended for asymptomatic and early symptomatic human immunodeficiency virus (HIV) infection. The best time to initiate zidovudine treatment remains uncertain, however, and whether early treatment improves survival has not been estab
Autor:
R L, Murphy, J P, Lavelle, J D, Allan, F M, Gordin, R, Dupliss, S L, Boswell, H A, Waskin, S F, Davies, F M, Graziano, M S, Saag
Publikováno v:
The American journal of medicine. 90(4)
To compare the efficacy and safety of three different doses of prophylactic aerosol pentamidine in patients with one prior episode of Pneumocystis carinii pneumonia (PCP) and the acquired immunodeficiency syndrome.The design of the study was a double
Autor:
D N, Burns, A, Kramer, F, Yellin, D, Fuchs, H, Wachter, R A, DiGioia, W C, Sanchez, R J, Grossman, F M, Gordin, R J, Biggar
Publikováno v:
Journal of acquired immune deficiency syndromes. 4(1)
Two hundred and two homosexual men enrolled in a prospective cohort study of AIDS risk were assessed for differences in the occurrence and progression of human immunodeficiency virus type 1 (HIV-1) infection with respect to cigarette smoking. Among s
Publikováno v:
Antimicrobial Agents and Chemotherapy. 31:398-403
Gram-negative bacillary pneumonia is a major cause of morbidity and mortality in hospitalized patients. The use of synergistic combinations of aminoglycosides and beta-lactams for therapy of this infection has been recommended but remains controversi
Pefloxacin and ciprofloxacin are two new quinoline carboxylic acid derivatives that have activity in vitro against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa. Using a well-standardized model of Pseudomonas pneumonia in n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1181b90488d4a7f09d4738ca3482eda4
https://europepmc.org/articles/PMC180073/
https://europepmc.org/articles/PMC180073/